SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000082
Filing Date
2020-05-27
Accepted
2020-05-26 17:43:19
Documents
14
Period of Report
2020-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x05x26pressrel.htm   iXBRL 8-K 54009
  Complete submission text file 0001367644-20-000082.txt   202141

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200526.xsd EX-101.SCH 4492
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200526_cal.xml EX-101.CAL 662
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200526_def.xml EX-101.DEF 1512
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200526_lab.xml EX-101.LAB 27268
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200526_pre.xml EX-101.PRE 14152
11 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x05x26pressrel_htm.xml XML 4630
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 20911998
SIC: 2834 Pharmaceutical Preparations